Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 79

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma

Bogusz, Agnieszka, Boekhoff, Svenja, Warmuth-Metz, Monika, Calaminus, Gabriele, Eveslage, Maria, Müller, Hermann L · 2019 · Endocrine Connections

Abstract

Objective: Quality of life (QoL) is frequently impaired in childhood-onset craniopharyngioma (CP) by hypothalamic syndrome. The debate, whether pretreatment hypothalamic involvement (HI) has apriori prognostic impact or surgical hypothalamic lesions (HL) determine outcome, is controversial. Design: Survival and outcome of CPs recruited between 2007 and 2014 in KRANIOPHARYNGEOM 2007 were analyzed with regard to reference-confirmed presurgical HI and surgical HL. Methods: Radiological findings, BMI and QoL were assessed at diagnosis and during follow-up. QoL was assessed using Pediatric Quality of Life (PEDQOL) questionnaire. Results: One hundred sixty-nine CPs were included presenting with no HI ( n = 11), anterior ( n = 49) and anterior + posterior (a + p) HI ( n = 109) prior to surgery. The latter 109 were analyzed for postoperative HL (no lesion: n = 23, anterior HL: n = 29, a + pHL: n = 57). Progression-free survival (PFS) was higher after complete resection. The highest PFS was observed in CP with a + pHL, especially when compared between non-irradiated subgroups ( P = 0.006). Overall survival (OS) rates were 1.0 in all subgroups. CP with a + pHL developed higher BMI ( P ≤ 0.001) during follow-up compared between subgroups. 55/109 pts with a + pHI completed PEDQOL at diagnosis (48/109 at 3 years follow-up). QoL was worse for a + pHL patients in terms of physical, social and emotional functionality when compared with the anterior HL and no HL subgroup. BMI development and QoL during follow-up were similar for patients with anterior HL and without HL. Conclusions: Posterior hypothalamus-sparing surgical strategies are associated with higher QoL, decreased development of obesity and lower PFS in CP.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1530/ec-19-0074

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 95

  1. 1996, Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted?, Journal of Neurosurgery, 85, 73, 10.3171/jns.1996.85.1.0073 · DOI · Paper page
  2. 2016, Preoperative staging in childhood craniopharyngioma: standardization as a first step towards improved outcome, Endocrine, 51, 1, 10.1007/s12020-015-0800-x · DOI
  3. 2001, Obesity after childhood craniopharyngioma – German multicenter study on pre-operative risk factors and quality of life, Klinische Padiatrie, 213, 244, 10.1055/s-2001-16855 · DOI · Paper page
  4. 2012, Xanthogranuloma, Rathke’s cyst, and childhood craniopharyngioma: results of prospective multinational studies of children and adolescents with rare sellar malformations, Journal of Clinical Endocrinology and Metabolism, 97, 3935, 10.1210/jc.2012-2069 · DOI · Paper page
  5. 2011, Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment, Frontiers in Endocrinology, 2, 60
  6. 2010, Magnetic resonance imaging-graded hypothalamic compression in surgically treated adult craniopharyngiomas determining postoperative obesity, Neurosurgical Focus, 28, E3, 10.3171/2010.1.FOCUS09303 · DOI
  7. 1988, Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain, Acta Paediatrica Scandinavica, 77, 587, 10.1111/j.1651-2227.1988.tb10705.x · DOI
  8. 2011, Consequences of craniopharyngioma surgery in children, Journal of Clinical Endocrinology and Metabolism, 96, 1981, 10.1210/jc.2011-0174 · DOI · Paper page
  9. 2013, Surgery for craniopharyngioma, Pituitary, 16, 18, 10.1007/s11102-012-0414-8 · DOI
  10. 2011, Surgical strategies in childhood craniopharyngioma, Frontiers in Endocrinology, 2, 96
  11. 2010, Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma, Journal of Clinical Endocrinology and Metabolism, 95, 5395, 10.1210/jc.2010-0993 · DOI
  12. 2016, Magnetic resonance imaging as predictor of functional outcome in craniopharyngiomas, Endocrine, 51, 148, 10.1007/s12020-015-0683-x · DOI
  13. 2011, Consequences of craniopharyngioma surgery in children, Journal of Clinical Endocrinology and Metabolism, 96, 1981, 10.1210/jc.2011-0174 · DOI · Paper page
  14. 2018, Low concordance between surgical and radiological assessment of degree of resection and treatment-related hypothalamic damage: results of KRANIOPHARYNGEOM 2007, Pituitary, 21, 371, 10.1007/s11102-018-0883-5 · DOI
  15. 1996, Munster Heidelberg abilities scale – a measuring instrument for global comparison of illness sequelae, Klinische Padiatrie, 208, 294
  16. 2011, Diagnostics, treatment, and follow-up in craniopharyngioma, Frontiers in Endocrinology, 2, 70
  17. 2018, Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007, Endocrine, 59, 364, 10.1007/s12020-017-1489-9 · DOI · Paper page
  18. 2013, Patterns of care for craniopharyngioma: survey of members of the American Association of Neurological Surgeons, Pediatric Neurosurgery, 49, 131, 10.1159/000357783 · doi:10.1159/000357783
  19. 2017, New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma, Nature Reviews Endocrinology, 13, 299, 10.1038/nrendo.2016.217 · DOI · Paper page
  20. 1989, Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development, Helvetica Paediatrica Acta Supplementum, 52, 1
  21. 2011, Diagnostics, treatment, and follow-up in craniopharyngioma, Frontiers in Endocrinology, 2, 70
  22. 2015, Hypothalamic obesity in craniopharyngioma patients: disturbed energy homeostasis related to extent of hypothalamic damage and its implication for obesity intervention, Journal of Clinical Medicine, 4, 1774, 10.3390/jcm4091774 · DOI
  23. 2006, Central nervous system control of food intake and body weight, Nature, 443, 289, 10.1038/nature05026 · DOI · Paper page
  24. 2011, Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up, European Journal of Endocrinology, 165, 17, 10.1530/EJE-11-0158 · DOI · Paper page
  25. 2018, The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up, European Journal of Endocrinology, 178, 11, 10.1530/EJE-17-0387 · DOI
  26. 2003, Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial, Journal of Clinical Endocrinology and Metabolism, 88, 2586, 10.1210/jc.2002-030003 · DOI · Paper page
  27. 2011, Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up, European Journal of Endocrinology, 165, 17, 10.1530/EJE-11-0158 · DOI · Paper page
  28. 2004, Prognosis and sequela in patients with childhood craniopharyngioma – results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000, Klinische Padiatrie, 216, 343, 10.1055/s-2004-832339 · DOI
  29. 2015, Hypothalamic obesity in craniopharyngioma patients: disturbed energy homeostasis related to extent of hypothalamic damage and its implication for obesity intervention, Journal of Clinical Medicine, 4, 1774, 10.3390/jcm4091774 · DOI
  30. 2013, Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity, Journal of Clinical Endocrinology and Metabolism, 98, 2376, 10.1210/jc.2012-3928 · DOI · Paper page
  31. 2013, Paediatrics: surgical strategy and quality of life in craniopharyngioma, Nature Reviews Endocrinology, 9, 447, 10.1038/nrendo.2013.125 · DOI
  32. 2005, Endocrine and neuroanatomic features associated with weight gain and obesity in adult patients with hypothalamic damage, American Journal of Medicine, 118, 45, 10.1016/j.amjmed.2004.06.035 · DOI
  33. 2013, Paediatrics: surgical strategy and quality of life in craniopharyngioma, Nature Reviews Endocrinology, 9, 447, 10.1038/nrendo.2013.125 · DOI
  34. 2014, Craniopharyngioma, Endocrine Reviews, 35, 513, 10.1210/er.2013-1115 · DOI · Paper page
  35. 2011, A novel rodent model that mimics the metabolic sequelae of obese craniopharyngioma patients, Pediatric Research, 69, 230, 10.1203/PDR.0b013e3182083b67 · DOI · Paper page
  36. 2014, Childhood craniopharyngioma – changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007, Klinische Padiatrie, 226, 161, 10.1055/s-0034-1368785 · DOI · Paper page
  37. 2015, Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden, Journal of Clinical Endocrinology and Metabolism, 100, 467, 10.1210/jc.2014-3525 · DOI · Paper page
  38. 2015, Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma, Neuropathology and Applied Neurobiology, 41, 721, 10.1111/nan.12226 · DOI · Paper page
  39. 2009, Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy, European Journal of Endocrinology, 161, 671, 10.1530/EJE-09-0449 · DOI
  40. 2018, The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up, European Journal of Endocrinology, 178, 11, 10.1530/EJE-17-0387 · DOI
  41. 2000, Quality of life in children and adolescents with cancer. First results of an evaluation of 49 patients with the PEDQOL questionnaire, Klinische Padiatrie, 212, 211, 10.1055/s-2000-9679 · DOI
  42. 2002, Craniopharyngioma: the St. Jude Children’s Research Hospital experience 1984–2001, International Journal of Radiation Oncology, Biology, Physics, 53, 533, 10.1016/S0360-3016(02)02799-2 · DOI · Paper page
  43. 2010, Hypothalamic obesity, Endocrine Development, 17, 185, 10.1159/000262539 · doi:10.1159/000262539
  44. 2012, Hypothalamic obesity in children, Obesity Reviews, 13, 780, 10.1111/j.1467-789X.2012.01004.x · DOI
  45. 2015, Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes, Neuro-Oncology, 17, 1029, 10.1093/neuonc/nov044 · DOI · Paper page
  46. 2002, Craniopharyngioma: the St. Jude Children’s Research Hospital experience 1984–2001, International Journal of Radiation Oncology, Biology, Physics, 53, 533, 10.1016/S0360-3016(02)02799-2 · DOI · Paper page
  47. 2005, Functional capacity and body mass index in patients with sellar masses – cross-sectional study on 403 patients diagnosed during childhood and adolescence, Child’s Nervous System, 21, 539, 10.1007/s00381-005-1166-9 · DOI
  48. 2005, Functional capacity and body mass index in patients with sellar masses – cross-sectional study on 403 patients diagnosed during childhood and adolescence, Child’s Nervous System, 21, 539, 10.1007/s00381-005-1166-9 · DOI
  49. 2013, Trends in treatment and outcomes of pediatric craniopharyngioma, 1975–2011, Neuro-Oncology, 15, 767, 10.1093/neuonc/not026 · DOI
  50. 2012, Hypothalamic obesity in children, Obesity Reviews, 13, 780, 10.1111/j.1467-789X.2012.01004.x · DOI
  51. 2010, Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma, Journal of Clinical Endocrinology and Metabolism, 95, 5395, 10.1210/jc.2010-0993 · DOI
  52. 2004, Differential diagnosis of suprasellar tumors in children, Klinische Padiatrie, 216, 323, 10.1055/s-2004-832358 · DOI
  53. 2018, Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007, Endocrine, 59, 364, 10.1007/s12020-017-1489-9 · DOI · Paper page
  54. 2014, Childhood craniopharyngioma – changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007, Klinische Padiatrie, 226, 161, 10.1055/s-0034-1368785 · DOI · Paper page
  55. 2015, Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity, Obesity, 23, 1226, 10.1002/oby.21067 · DOI · Paper page
  56. 1991, Body mass index variations: centiles from birth to 87 years, European Journal of Clinical Nutrition, 45, 13
  57. 2004, Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma, Journal of Clinical Endocrinology and Metabolism, 89, 3298, 10.1210/jc.2003-031751 · DOI · Paper page
  58. 2011, Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment, Frontiers in Endocrinology, 2, 60
  59. 2015, Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma, Neuropathology and Applied Neurobiology, 41, 721, 10.1111/nan.12226 · DOI · Paper page
  60. 2009, Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy, European Journal of Endocrinology, 161, 671, 10.1530/EJE-09-0449 · DOI
  61. 2004, Differential diagnosis of suprasellar tumors in children, Klinische Padiatrie, 216, 323, 10.1055/s-2004-832358 · DOI
  62. 2005, Endocrine and neuroanatomic features associated with weight gain and obesity in adult patients with hypothalamic damage, American Journal of Medicine, 118, 45, 10.1016/j.amjmed.2004.06.035 · DOI
  63. 2015, Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes, Neuro-Oncology, 17, 1029, 10.1093/neuonc/nov044 · DOI · Paper page
  64. 2003, Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial, Journal of Clinical Endocrinology and Metabolism, 88, 2586, 10.1210/jc.2002-030003 · DOI · Paper page
  65. 1991, Body mass index variations: centiles from birth to 87 years, European Journal of Clinical Nutrition, 45, 13
  66. 2016, Magnetic resonance imaging as predictor of functional outcome in craniopharyngiomas, Endocrine, 51, 148, 10.1007/s12020-015-0683-x · DOI
  67. 2010, Magnetic resonance imaging-graded hypothalamic compression in surgically treated adult craniopharyngiomas determining postoperative obesity, Neurosurgical Focus, 28, E3, 10.3171/2010.1.FOCUS09303 · DOI
  68. 2007, Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement, Journal of Neurosurgery, 106, 3
  69. 2007, Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement, Journal of Neurosurgery, 106, 3
  70. 2000, Quality of life in children and adolescents with cancer. First results of an evaluation of 49 patients with the PEDQOL questionnaire, Klinische Padiatrie, 212, 211, 10.1055/s-2000-9679 · DOI
  71. 2003, Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity, Journal of Clinical Endocrinology and Metabolism, 88, 5227, 10.1210/jc.2002-021797 · DOI · Paper page
  72. 1989, Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development, Helvetica Paediatrica Acta Supplementum, 52, 1
  73. 1996, Munster Heidelberg abilities scale – a measuring instrument for global comparison of illness sequelae, Klinische Padiatrie, 208, 294
  74. 2004, Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma, Journal of Clinical Endocrinology and Metabolism, 89, 3298, 10.1210/jc.2003-031751 · DOI · Paper page
  75. 2014, Craniopharyngioma, Endocrine Reviews, 35, 513, 10.1210/er.2013-1115 · DOI · Paper page
  76. 2013, Trends in treatment and outcomes of pediatric craniopharyngioma, 1975–2011, Neuro-Oncology, 15, 767, 10.1093/neuonc/not026 · DOI
  77. 2016, Preoperative staging in childhood craniopharyngioma: standardization as a first step towards improved outcome, Endocrine, 51, 1, 10.1007/s12020-015-0800-x · DOI
  78. 2010, Hypothalamic obesity, Endocrine Development, 17, 185, 10.1159/000262539 · doi:10.1159/000262539
  79. 2011, Surgical strategies in childhood craniopharyngioma, Frontiers in Endocrinology, 2, 96
  80. 2004, Prognosis and sequela in patients with childhood craniopharyngioma – results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000, Klinische Padiatrie, 216, 343, 10.1055/s-2004-832339 · DOI
  81. 2013, Surgery for craniopharyngioma, Pituitary, 16, 18, 10.1007/s11102-012-0414-8 · DOI
  82. 1996, Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted?, Journal of Neurosurgery, 85, 73, 10.3171/jns.1996.85.1.0073 · DOI · Paper page
  83. 2012, Xanthogranuloma, Rathke’s cyst, and childhood craniopharyngioma: results of prospective multinational studies of children and adolescents with rare sellar malformations, Journal of Clinical Endocrinology and Metabolism, 97, 3935, 10.1210/jc.2012-2069 · DOI · Paper page
  84. 2018, Low concordance between surgical and radiological assessment of degree of resection and treatment-related hypothalamic damage: results of KRANIOPHARYNGEOM 2007, Pituitary, 21, 371, 10.1007/s11102-018-0883-5 · DOI
  85. 2006, Craniopharyngiomas, Endocrine Reviews, 27, 371, 10.1210/er.2006-0002 · DOI · Paper page
  86. 2005, Craniopharyngioma: the pendulum of surgical management, Child’s Nervous System, 21, 691, 10.1007/s00381-005-1209-2 · DOI
  87. 2001, Obesity after childhood craniopharyngioma – German multicenter study on pre-operative risk factors and quality of life, Klinische Padiatrie, 213, 244, 10.1055/s-2001-16855 · DOI · Paper page
  88. 2017, Very long-term sequelae of craniopharyngioma, European Journal of Endocrinology, 176, 755, 10.1530/EJE-17-0044 · DOI
  89. 2015, Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden, Journal of Clinical Endocrinology and Metabolism, 100, 467, 10.1210/jc.2014-3525 · DOI · Paper page
  90. 2017, Very long-term sequelae of craniopharyngioma, European Journal of Endocrinology, 176, 755, 10.1530/EJE-17-0044 · DOI
  91. 2013, Patterns of care for craniopharyngioma: survey of members of the American Association of Neurological Surgeons, Pediatric Neurosurgery, 49, 131, 10.1159/000357783 · doi:10.1159/000357783
  92. 2005, Craniopharyngioma: the pendulum of surgical management, Child’s Nervous System, 21, 691, 10.1007/s00381-005-1209-2 · DOI
  93. 2017, New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma, Nature Reviews Endocrinology, 13, 299, 10.1038/nrendo.2016.217 · DOI · Paper page
  94. 2013, Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity, Journal of Clinical Endocrinology and Metabolism, 98, 2376, 10.1210/jc.2012-3928 · DOI · Paper page
  95. 1988, Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain, Acta Paediatrica Scandinavica, 77, 587, 10.1111/j.1651-2227.1988.tb10705.x · DOI

Cited by

See all 79

Metadata

Authors
Bogusz, A., Boekhoff, S., Warmuth-Metz, M., Calaminus, G., Eveslage, M., & Müller, H. L.
Affiliations
  • 1Department of Pediatrics and Pediatric Hematology/Oncology, University Children’s Hospital, Klinikum Oldenburg AöR, Oldenburg, Germany
  • 3Department of Neuroradiology, University Hospital, Würzburg, Germany
  • 4Department of Pediatric Oncology and Hematology, University Hospital, Bonn, Germany
  • 5Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany
Venue
Endocrine Connections
Published
2019-05
Volume
8
Issue
5
Pages
481-492
ISSN
2049-3614
Cited by
79
References
5

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.